Wharton J - Search Results

1

Therapeutic targets in pulmonary arterial hypertension.

Rhodes CJ, Davidson A, Gibbs JS, Wharton J, Wilkins MR. Rhodes CJ, et al. Among authors: wharton j. Pharmacol Ther. 2009 Jan;121(1):69-88. doi: 10.1016/j.pharmthera.2008.10.002. Epub 2008 Oct 28. Pharmacol Ther. 2009. PMID: 19010350 Review.

2

Identification of renal natriuretic peptide receptor subpopulations by use of the non-peptide antagonist, HS-142-1.

Rutherford RA, Matsuda Y, Wilkins MR, Polak JM, Wharton J. Rutherford RA, et al. Among authors: wharton j. Br J Pharmacol. 1994 Nov;113(3):931-9. doi: 10.1111/j.1476-5381.1994.tb17082.x. Br J Pharmacol. 1994. PMID: 7858888 Free PMC article.

3

The natriuretic peptide family: turning hormones into drugs.

Wilkins MR, Nunez DJ, Wharton J. Wilkins MR, et al. Among authors: wharton j. J Endocrinol. 1993 Jun;137(3):347-59. doi: 10.1677/joe.0.1370347. J Endocrinol. 1993. PMID: 8371073 Review. No abstract available.

4

Downregulation of natriuretic peptide C-receptor protein in the hypertrophied ventricle of the aortovenocaval fistula rat.

Brown LA, Rutherford RA, Nunez DJ, Wharton J, Lowe DG, Wilkins MR. Brown LA, et al. Among authors: wharton j. Cardiovasc Res. 1997 Dec;36(3):363-71. doi: 10.1016/s0008-6363(97)00192-2. Cardiovasc Res. 1997. PMID: 9534857

5

Progress in, and future prospects for, the treatment of primary pulmonary hypertension.

Wilkins MR, Wharton J. Wilkins MR, et al. Among authors: wharton j. Heart. 2001 Dec;86(6):603-4. doi: 10.1136/heart.86.6.603. Heart. 2001. PMID: 11711446 Free PMC article. No abstract available.

6

Developments in therapeutics for pulmonary arterial hypertension.

Wilkins MR, Møller GM, Ren X, Wharton J. Wilkins MR, et al. Among authors: wharton j. Minerva Cardioangiol. 2002 Jun;50(3):175-87. Minerva Cardioangiol. 2002. PMID: 12107399 Review.

7

Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.

Wharton J, Strange JW, Møller GM, Growcott EJ, Ren X, Franklyn AP, Phillips SC, Wilkins MR. Wharton J, et al. Am J Respir Crit Care Med. 2005 Jul 1;172(1):105-13. doi: 10.1164/rccm.200411-1587OC. Epub 2005 Apr 7. Am J Respir Crit Care Med. 2005. PMID: 15817798

8

Phosphodiesterase type 5 and high altitude pulmonary hypertension.

Aldashev AA, Kojonazarov BK, Amatov TA, Sooronbaev TM, Mirrakhimov MM, Morrell NW, Wharton J, Wilkins MR. Aldashev AA, et al. Among authors: wharton j. Thorax. 2005 Aug;60(8):683-7. doi: 10.1136/thx.2005.041954. Thorax. 2005. PMID: 16061711 Free PMC article. Clinical Trial.

9

Emerging therapies for pulmonary arterial hypertension.

Ali O, Wharton J, Gibbs JS, Howard L, Wilkins MR. Ali O, et al. Among authors: wharton j. Expert Opin Investig Drugs. 2007 Jun;16(6):803-18. doi: 10.1517/13543784.16.6.803. Expert Opin Investig Drugs. 2007. PMID: 17501693 Review.

10

Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.

Diller GP, van Eijl S, Okonko DO, Howard LS, Ali O, Thum T, Wort SJ, Bédard E, Gibbs JS, Bauersachs J, Hobbs AJ, Wilkins MR, Gatzoulis MA, Wharton J. Diller GP, et al. Among authors: wharton j. Circulation. 2008 Jun 10;117(23):3020-30. doi: 10.1161/CIRCULATIONAHA.108.769646. Epub 2008 Jun 2. Circulation. 2008. PMID: 18519847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

582 results

Search Page

Filters